Neoadjuvant personalized cancer vaccines: the final frontier?

by Elena Iemma | Jan 15, 2024

Neoantigen-based personalized cancer vaccines: the emergence of precision cancer immunotherapy

by Elena Iemma | Dec 9, 2021

Bridging Computational Vaccinology and Vaccine Development Through Systematic Identification, Characterization, and Downselection of Conserved and Variable Circumsporozoite Protein CD4 T Cell Epitopes From Diverse Plasmodium falciparum Strains

by Elena Iemma | Jun 8, 2021

Integrated Approaches for Design of Precision Cancer Immunotherapies: Selection of Class I and Class II T cell Neo-Epitopes and Removal Treg Epitopes

by Annie De Groot | Mar 1, 2019

2018 Design of Cancer Immunotherapies – Selection of Neo-Epitopes, Removal of Tregitopes

Disease Status Explained by Neo-epitopes with Low Potential for Activating Regulatory T cells: an Application of Precision Cancer Immunotherapy Design Tools to Bladder Cancer

by Annie De Groot | Oct 8, 2018

EpiVax_poster_Disease Status Explained by Neo-Epitopes with Low Potential for Activating Regulatory T Cells